Project: Metrology for MR guided radiotherapy

Cancer, the leading cause of death in Europe after cardiovascular disease, is responsible for roughly one in five deaths. Radiotherapy, which uses beams of ionising radiation to kill cancerous cells, is one of our most important defences against cancer and is used to treat around half of patients in Europe. One emerging technique, magnetic resonance (MR)-guided radiotherapy, provides real-time images of a patient during treatment, and offers more detailed and higher contrast images for the identification of tumours and soft tissues than conventional techniques. This boosts tumour targeting accuracy, reducing side-effects and increasing survival rates. Accurate radiation dose is crucial to the safe and effective treatment of patients, but radiation transport is strongly affected by the magnetic fields used in MR-guided radiotherapy. This project will develop new standards and measurement methods, adapted for MR-guided radiotherapy, to enable medical physicists to develop safe, accurate treatment plans. This metrological framework will support the clinical implementation of MR-guided radiotherapy, accelerating the rollout of this state-of-the-art treatment.

Acronym 15HLT08 MRgRT (Reference Number: 15HLT08)
Duration 01/06/2016 - 01/06/2019
Project Topic Metrology
Project Results
(after finalisation)
See Website
Website visit project website
Network EMPIR
Call EMPIR CALL 2015

Project partner

Number Name Role Country
1 VSL B.V. Coordinator Netherlands
2 Commissariat à l'énergie atomique et aux énergies alternatives Partner France
3 NPL Management Limited Partner United Kingdom
4 Physikalisch-Technische Bundesanstalt Partner Germany
5 Deutsches Krebsforschungszentrum Partner Germany
6 Universitair Medisch Centrum Utrecht Partner Netherlands
7 The University of Manchester Partner United Kingdom
8 The Christie NHS Foundation Trust Observer United Kingdom
9 Eidgenössisches Institut für Metrologie METAS Observer Switzerland